1-3 of 3
Patrick O'Connor
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract B123: Novel high content molecular characterization and anticancer drug sensitivity profiling of more clinically relevant tumor models derived from patient primary tumors.

Kesavan Praveen Nair, Nicole Streiner, Steve Hoffmaster, Martin Vo, Thomas Broudy, Cyrus Mirsaidi, Patrick O'Connor, Kenna Anderes
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2011) 10 (11_Supplement): B123.
https://doi.org/10.1158/1535-7163.TARG-11-B123
Published: 12 November 2011
View article titled, Abstract B123: Novel high content molecular characterization and anticancer drug sensitivity profiling of more clinically relevant tumor models derived from patient primary tumors.
Journal Articles

Breaching the DNA damage checkpoint via PF-00477736, a novel small-molecule inhibitor of checkpoint kinase 1

Alessandra Blasina, Jill Hallin, Enhong Chen, Maria Elena Arango, Eugenia Kraynov, James Register, Stephan Grant, Sacha Ninkovic, Ping Chen, Tim Nichols, Patrick O'Connor, Kenna Anderes
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2008) 7 (8): 2394–2404.
https://doi.org/10.1158/1535-7163.MCT-07-2391
Published: 21 August 2008
View article titled, Breaching the DNA damage checkpoint via PF-00477736, a novel small-molecule inhibitor of checkpoint kinase 1
Open the PDF for Breaching the DNA damage checkpoint via PF-00477736, a novel small-molecule inhibitor of checkpoint kinase 1 in another window
Includes: Supplementary data
Journal Articles

Pharmacologic properties of AG-012986, a pan-cyclin-dependent kinase inhibitor with antitumor efficacy

Cathy Zhang, Karen Lundgren, Zhengming Yan, Maria E. Arango, Sharon Price, Andrea Huber, Joseph Higgins, Gabriel Troche, Judith Skaptason, Tatiana Koudriakova, Jim Nonomiya, Michelle Yang, Patrick O'Connor, Steve Bender, Gerrit Los, Cristina Lewis, Bart Jessen
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2008) 7 (4): 818–828.
https://doi.org/10.1158/1535-7163.MCT-07-0440
Published: 15 April 2008
View article titled, Pharmacologic properties of AG-012986, a pan-cyclin-dependent kinase inhibitor with antitumor efficacy
Open the PDF for Pharmacologic properties of AG-012986, a pan-cyclin-dependent kinase inhibitor with antitumor efficacy in another window